Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD

CONTEXT: Recombinant human growth hormone (rhGH) is approved for treatment of pediatric growth hormone deficiency (GHD), with greatest growth responses observed in those with severe GHD. Orally administered GH secretagogues (GHS) may be useful treatment in patients with moderate GHD. Distinguishing...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Blum, Werner F, Bright, George M, Do, Minh-Ha T, McKew, John C, Chen, Haiying, Thorner, Michael O
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Clinical Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8101276/
https://ncbi.nlm.nih.gov/pubmed/33982678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab029
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky